Hospital Revenues Appear To Be Rising

Hospital revenues appear to be on the upswing as more patients receive care — which is welcome news for the hospital industry and not-so-great for insurers.

Why it matters: Hospitals have been warning for months that their financial stability is threatened by inflation, labor costs and other factors in the wake of the pandemic, which could ultimately threaten patient care.

Driving the news: In response to a Cowen survey, more than 300 non-profit hospitals reported a 7.5% year-to-year revenue growth in May, a sharp acceleration above April’s 3.5% growth rate and a 4.7% growth rate in the first quarter.

  • “Most of this acceleration is clearly happening on the outpatient side,” Cowen analysts wrote in a note.
  • On Tuesday evening, UnitedHealth Group said costs are rising as more older adults are receiving outpatient care, including hip and knee procedures, causing insurer stocks to tumble yesterday, per Reuters.

Between the lines: This may just be the beginning of hospital spending increases.

  • Although the recent spikes appear to largely be due to pent-up demand, the delayed impact of economy-wide inflation — which takes awhile to trickle through the health system — could continue to drive prices upward as providers renegotiate contracts with insurers.

What we’re watching: Hospitals’ revenue problems have provided the industry with a timely reason to rail against congressional efforts to reform how Medicare reimburses them.

  • But if data continues to show that hospitals’ financial fortunes have reversed, that could bolster lawmakers’ resolve to pass reforms.

 

Source Link

Recommended Articles

New NFIB Survey: Small Businesses Report Reduced Optimism

The NFIB Small Business Optimism Index fell 0.6 points in May to 95.3, remaining below its 52-year average of 98.0. The Uncertainty Index rose 3 points from April to 91, remaining well above its historical average of 68. As reported in NFIB’s monthly Jobs Report, the NFIB Small Business Employment Index remained essentially flat, registering 100.3 in May. ...

Read More

Trump Announces TrumpRx Expansion, Adding 160 More Drugs

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months. “I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” ...

Read More

Skyrocketing GLP-1 Demand Creates Major Financial Strain For Employers

GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...

Read More

Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas

A Trump administration initiative to impose $100,000 fees on employers seeking visas for skilled foreign workers amounts to an unlawful tax on those companies and must be voided “in its entirety,” a federal judge ruled on Monday. The decision by Judge Leo T. Sorokin of the Federal District Court for the District of Massachusetts nullified ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square